Plain-English translation of NCT05957354 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Stroke research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called continuous theta burst stimulation (cTBS)—a type of magnetic brain stimulation—to help people recover their ability to speak after a stroke. The treatment uses personalized brain scans to identify exactly where to apply the stimulation for each patient, making it more precise and tailored to your individual needs. You would receive this treatment combined with speech therapy over three weeks.
Aphasia, the loss of ability to speak or understand language after a stroke, is a serious condition that significantly impacts quality of life. While some recovery happens naturally, many patients have permanent speech difficulties. This trial is exploring whether this new brain stimulation approach, combined with speech therapy, could help patients recover more of their language ability than traditional therapy alone.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either the active brain stimulation treatment or a sham (fake) treatment, both combined with speech language therapy. Your treatment will take place over 3 weeks, with sessions on weekdays only (15 total sessions). During each session, you'll receive the stimulation using special equipment that guides the treatment to the exact location identified in your personalized brain scans, followed by speech therapy. You'll be closely monitored throughout to ensure safety.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
China